MedTrace Logo

Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect

NCT01491867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2013-03-22

No results posted yet for this study

Summary

Continuous intraocular pressure (IOP) measurement with a contact lens sensor may provide more information on the drug-related IOP change than 24-hour IOP measurement with Goldmann applanation tonometry (GAT.

Conditions

Interventions

DRUG

travoprost 0.003%

Instillation of travoprost 0.003% 1/die in both eyes for 3 months

Sponsors & Collaborators

  • Semmelweis University

    lead OTHER

Principal Investigators

  • Gabor Hollo, MD · Semmelweis University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01491867 on ClinicalTrials.gov